{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:22:11Z","timestamp":1791177731071,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00347-022-01630-6","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T10:03:32Z","timestamp":1650967412000},"page":"533-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sekund\u00e4re Offenwinkelglaukome: uveitische Sekund\u00e4rglaukome, Steroidglaukom, posttraumatische\/postoperative Glaukome, tumorbedingte Glaukome und Glaukome im Rahmen eines erh\u00f6hten episkleralen Venendrucks","Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure"],"prefix":"10.1007","volume":"119","author":[{"given":"Roman","family":"Greslechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlev","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"1630_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2021-egsguidelines","volume":"105","author":"EGS","year":"2021","unstructured":"EGS (2021) European Glaucoma Society terminology and guidelines for glaucoma, 5th Edition. Br J Ophthalmol 105:1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines","journal-title":"Br J Ophthalmol"},{"key":"1630_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs\u00a0DA, Nussenblatt\u00a0RB, Rosenbaum\u00a0JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"1630_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0039-6257(97)00006-4","volume":"41","author":"RS Moorthy","year":"1997","unstructured":"Moorthy\u00a0RS, Mermoud\u00a0A, Baerveldt\u00a0G et\u00a0al (1997) Glaucoma associated with uveitis. Surv Ophthalmol 41:361\u2013394. https:\/\/doi.org\/10.1016\/s0039-6257(97)00006-4","journal-title":"Surv Ophthalmol"},{"key":"1630_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1055\/a-0573-9598","volume":"235","author":"C Lommatzsch","year":"2018","unstructured":"Lommatzsch\u00a0C, Heinz\u00a0C (2018) Sekund\u00e4rglaukom bei Uveitis. Klin Monbl Augenheilkd 235:576\u2013585. https:\/\/doi.org\/10.1055\/a-0573-9598","journal-title":"Klin Monbl Augenheilkd"},{"key":"1630_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0002-9394(98)00071-3","volume":"126","author":"RD Fechtner","year":"1998","unstructured":"Fechtner\u00a0RD, Khouri\u00a0AS, Zimmerman\u00a0TJ et\u00a0al (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126:37\u201341. https:\/\/doi.org\/10.1016\/s0002-9394(98)00071-3","journal-title":"Am J Ophthalmol"},{"key":"1630_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.survophthal.2008.08.004","volume":"53","author":"A Alm","year":"2008","unstructured":"Alm\u00a0A, Grierson\u00a0I, Shields\u00a0MB (2008) Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 53:93\u2013S105. https:\/\/doi.org\/10.1016\/j.survophthal.2008.08.004","journal-title":"Surv Ophthalmol"},{"key":"1630_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/ijg.0b013e3182685167","volume":"23","author":"K Iwao","year":"2014","unstructured":"Iwao\u00a0K, Inatani\u00a0M, Seto\u00a0T et al (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a\u00a0retrospective cohort study. J\u00a0Glaucoma 23:88\u201394. https:\/\/doi.org\/10.1097\/ijg.0b013e3182685167","journal-title":"J Glaucoma"},{"key":"1630_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00347-013-2888-9","volume":"111","author":"K Wiese","year":"2014","unstructured":"Wiese\u00a0K, Heiligenhaus\u00a0A, Heinz\u00a0C (2014) Trabekulektomie bei juveniler idiopathischer Arthritis-assoziierter Uveitis. Ophthalmologe 111:330\u2013338. https:\/\/doi.org\/10.1007\/s00347-013-2888-9","journal-title":"Ophthalmologe"},{"key":"1630_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/ceo.12916","volume":"45","author":"HJ Kwon","year":"2017","unstructured":"Kwon\u00a0HJ, Kong\u00a0YXG, Tao\u00a0LW et\u00a0al (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472\u2013480. https:\/\/doi.org\/10.1111\/ceo.12916","journal-title":"Clin Exp Ophthalmol"},{"key":"1630_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ceo.13087","volume":"46","author":"CC Sng","year":"2018","unstructured":"Sng\u00a0CC, Wang\u00a0J, Hau\u00a0S et al (2018) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol 46:339\u2013345. https:\/\/doi.org\/10.1111\/ceo.13087","journal-title":"Clin Exp Ophthalmol"},{"key":"1630_CR11","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00417-016-3325-y","volume":"254","author":"C Lommatzsch","year":"2016","unstructured":"Lommatzsch\u00a0C, Heinz\u00a0C, Heiligenhaus\u00a0A, Koch\u00a0JM (2016) Canaloplasty in patients with uveitic glaucoma: a\u00a0pilot study. Graefes Arch Clin Exp Ophthalmol 254:1325\u20131330. https:\/\/doi.org\/10.1007\/s00417-016-3325-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/s0002-9394(02)01344-2","volume":"133","author":"SF Freedman","year":"2002","unstructured":"Freedman\u00a0SF, Rodriguez-Rosa\u00a0RE, Rojas\u00a0MC, Enyedi\u00a0LB (2002) Goniotomy for glaucoma secondary to chronic childhood uveitis. Am J Ophthalmol 133:617\u2013621. https:\/\/doi.org\/10.1016\/s0002-9394(02)01344-2","journal-title":"Am J Ophthalmol"},{"key":"1630_CR13","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00417-015-3102-3","volume":"253","author":"A Anton","year":"2015","unstructured":"Anton\u00a0A, Heinzelmann\u00a0S, Ne\u00df\u00a0T et\u00a0al (2015) Trabeculectomy ab interno with the Trabectome\u00ae as a\u00a0therapeutic option for uveitic secondary glaucoma. Graefes Arch Clin Exp Ophthalmol 253:1973\u20131978. https:\/\/doi.org\/10.1007\/s00417-015-3102-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1055\/s-0041-105941","volume":"232","author":"M Pahlitzsch","year":"2015","unstructured":"Pahlitzsch\u00a0M, Gonnermann\u00a0J, Maier\u00a0A\u2011K et al (2015) Trabekulotomie ab interno (Trabectome) \u2013 Kumulierte klinische Ergebnisse eines gro\u00dfen Glaukomkollektivs. Klin Monbl Augenheilkd 232:1198\u20131207. https:\/\/doi.org\/10.1055\/s-0041-105941","journal-title":"Klin Monbl Augenheilkd"},{"key":"1630_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bjo.84.9.999","volume":"84","author":"T Schlote","year":"2000","unstructured":"Schlote\u00a0T, Derse\u00a0M, Zierhut\u00a0M (2000) Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol 84:999\u20131003. https:\/\/doi.org\/10.1136\/bjo.84.9.999","journal-title":"Br J Ophthalmol"},{"key":"1630_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/bjo.2005.085936","volume":"90","author":"C Heinz","year":"2006","unstructured":"Heinz\u00a0C, Koch\u00a0JM, Heiligenhaus\u00a0A (2006) Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up. Br J Ophthalmol 90:737\u2013740. https:\/\/doi.org\/10.1136\/bjo.2005.085936","journal-title":"Br J Ophthalmol"},{"key":"1630_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00417-013-2558-2","volume":"252","author":"B Voykov","year":"2014","unstructured":"Voykov\u00a0B, Deuter\u00a0C, Zierhut\u00a0M et\u00a0al (2014) Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs uveitis syndrome? Graefes Arch Clin Exp Ophthalmol 252:485\u2013489. https:\/\/doi.org\/10.1007\/s00417-013-2558-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/978-3-662-60399-4","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"U Pleyer","year":"2021","unstructured":"Pleyer\u00a0U (2021) Herpes-Virus-assoziierte anteriore Uveitis. In: Pleyer\u00a0U (Hrsg) Entz\u00fcndliche Augenerkrankungen, 2.\u00a0Aufl. Springer, Berlin, S 476\u2013482 https:\/\/doi.org\/10.1007\/978-3-662-60399-4","edition":"2"},{"key":"1630_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00347-019-01028-x","volume":"117","author":"M Lenglinger","year":"2020","unstructured":"Lenglinger\u00a0M, Pohlmann\u00a0D, Pleyer\u00a0U (2020) Anteriore virale Uveitis. Ophthalmologe 117:83\u201392. https:\/\/doi.org\/10.1007\/s00347-019-01028-x","journal-title":"Ophthalmologe"},{"key":"1630_CR20","volume-title":"S2k-Leitlinie \u201eDiagnostik und Therapie des Zoster und der Postzosterneuralgie\u201c","author":"AWMF","year":"2019","unstructured":"AWMF (2019) S2k-Leitlinie \u201eDiagnostik und Therapie des Zoster und der Postzosterneuralgie\u201c"},{"key":"1630_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00347-011-2346-5","volume":"108","author":"B Seitz","year":"2011","unstructured":"Seitz\u00a0B, Heiligenhaus\u00a0A (2011) Herpeskeratitis. Ophthalmologe 108:385\u2013398. https:\/\/doi.org\/10.1007\/s00347-011-2346-5","journal-title":"Ophthalmologe"},{"key":"1630_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00347-017-0494-y","volume":"114","author":"L Daas","year":"2017","unstructured":"Daas\u00a0L, Seitz\u00a0B, Pleyer\u00a0U (2017) Fuchs-Uveitis. Ophthalmologe 114:481\u2013492. https:\/\/doi.org\/10.1007\/s00347-017-0494-y","journal-title":"Ophthalmologe"},{"key":"1630_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1600-0420.2007.00990.x","volume":"86","author":"K Norrsell","year":"2008","unstructured":"Norrsell\u00a0K, Sj\u00f6dell\u00a0L (2008) Fuchs heterochromic uveitis: a\u00a0longitudinal clinical study. Acta Ophthalmol 86:58\u201364. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00990.x","journal-title":"Acta Ophthalmol"},{"key":"1630_CR24","doi-asserted-by":"publisher","first-page":"1458624","DOI":"10.1155\/2016\/1458624","volume":"2016","author":"M Accorinti","year":"2016","unstructured":"Accorinti\u00a0M, Spinucci\u00a0G, Pirraglia\u00a0MP et\u00a0al (2016) Fuchs heterochromic iridocyclitis in an italian tertiary referral centre: epidemiology, clinical features and prognosis. J\u00a0Ophthalmol 2016:1458624. https:\/\/doi.org\/10.1155\/2016\/1458624","journal-title":"J Ophthalmol"},{"key":"1630_CR25","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/archopht.1985.01050120071023","volume":"103","author":"S Hirose","year":"1985","unstructured":"Hirose\u00a0S, Ohno\u00a0S, Matsuda\u00a0H (1985) HLA-Bw54 and glaucomatocyclitic crisis. Arch Ophthalmol 103:1837\u20131839. https:\/\/doi.org\/10.1001\/archopht.1985.01050120071023","journal-title":"Arch Ophthalmol"},{"key":"1630_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ajo.2008.09.001","volume":"146","author":"S-P Chee","year":"2008","unstructured":"Chee\u00a0S\u2011P, Jap\u00a0A (2008) Presumed fuchs heterochromic Iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol 146:883\u2013889.e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.09.001","journal-title":"Am J Ophthalmol"},{"key":"1630_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05291-0","author":"J-H Kim","year":"2021","unstructured":"Kim\u00a0J\u2011H, Lee\u00a0J\u2011Y, Choi\u00a0JA (2021) Long-term prognosis for glaucoma in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-021-05291-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR28","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","volume":"158","author":"C-C Su","year":"2014","unstructured":"Su\u00a0C\u2011C, Hu\u00a0F\u2011R, Wang\u00a0T\u2011H et al (2014) Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol 158:1024\u20131031.e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.08.007","journal-title":"Am J Ophthalmol"},{"key":"1630_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00417-013-2535-9","volume":"252","author":"B Sobolewska","year":"2014","unstructured":"Sobolewska\u00a0B, Deuter\u00a0C, Doycheva\u00a0D, Zierhut\u00a0M (2014) Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol 252:117\u2013124. https:\/\/doi.org\/10.1007\/s00417-013-2535-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR30","first-page":"198","volume":"4","author":"B Becker","year":"1965","unstructured":"Becker\u00a0B (1965) Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 4:198\u2013205","journal-title":"Invest Ophthalmol"},{"key":"1630_CR31","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/iae.0000000000001364","volume":"37","author":"EK Chin","year":"2017","unstructured":"Chin\u00a0EK, Almeida\u00a0DRP, Velez\u00a0G et al (2017) Ocular hypertension after intravitreal dexamethasone (ozurdex) sustained-release implant. Retina 37:1345\u20131351. https:\/\/doi.org\/10.1097\/iae.0000000000001364","journal-title":"Retina"},{"key":"1630_CR32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/eye.2017.125","volume":"31","author":"C Bailey","year":"2017","unstructured":"Bailey\u00a0C, Chakravarthy\u00a0U, Lotery\u00a0A et al (2017) Real-world experience with 0.2\u202f\u03bcg\/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom. Eye 31:1707\u20131715. https:\/\/doi.org\/10.1038\/eye.2017.125","journal-title":"Eye"},{"key":"1630_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000328630","volume":"47","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad\u00a0MR, Katz\u00a0LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47:66\u201380. https:\/\/doi.org\/10.1159\/000328630","journal-title":"Ophthalmic Res"},{"key":"1630_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly\u00a0MF (1963) Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 70:492\u2013499. https:\/\/doi.org\/10.1001\/archopht.1963.00960050494011","journal-title":"Arch Ophthalmol"},{"key":"1630_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.exer.2008.11.025","volume":"88","author":"O-Y Tektas","year":"2009","unstructured":"Tektas\u00a0O\u2011Y, L\u00fctjen-Drecoll\u00a0E (2009) Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res 88:769\u2013775. https:\/\/doi.org\/10.1016\/j.exer.2008.11.025","journal-title":"Exp Eye Res"},{"key":"1630_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00061198-200012000-00011","volume":"9","author":"M Honjo","year":"2000","unstructured":"Honjo\u00a0M, Tanihara\u00a0H, Inatani\u00a0M, Honda\u00a0Y (2000) External trabeculotomy for the treatment of steroid-induced glaucoma. J\u00a0Glaucoma 9:483\u2013485. https:\/\/doi.org\/10.1097\/00061198-200012000-00011","journal-title":"J Glaucoma"},{"key":"1630_CR37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/archopht.1992.01080180110037","volume":"110","author":"J Klopfer","year":"1992","unstructured":"Klopfer\u00a0J, Tielsch\u00a0JM, Vitale\u00a0S et\u00a0al (1992) Ocular trauma in the United States: eye injuries resulting in hospitalization, 1984 through 1987. Arch Ophthalmol 110:838\u2013842. https:\/\/doi.org\/10.1001\/archopht.1992.01080180110037","journal-title":"Arch Ophthalmol"},{"key":"1630_CR38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bjo.66.9.549","volume":"66","author":"YM Canavan","year":"1982","unstructured":"Canavan\u00a0YM, Archer\u00a0DB (1982) Anterior segment consequences of blunt ocular injury. Br J Ophthalmol 66:549\u2013555. https:\/\/doi.org\/10.1136\/bjo.66.9.549","journal-title":"Br J Ophthalmol"},{"key":"1630_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/01.ijg.0000185437.92803.d7","volume":"14","author":"CA Girkin","year":"2005","unstructured":"Girkin\u00a0CA, McGwin\u00a0G, Long\u00a0C et\u00a0al (2005) Glaucoma after ocular contusion: a\u00a0cohort study of the United States Eye Injury Register. J\u00a0Glaucoma 14:470\u2013473. https:\/\/doi.org\/10.1097\/01.ijg.0000185437.92803.d7","journal-title":"J Glaucoma"},{"key":"1630_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.1967.00980030716005","volume":"78","author":"GL Spaeth","year":"1967","unstructured":"Spaeth\u00a0GL (1967) Traumatic hyphema, angle recession, dexamethasone hypertension and glaucoma. Arch Ophthalmol 78:714\u2013721. https:\/\/doi.org\/10.1001\/archopht.1967.00980030716005","journal-title":"Arch Ophthalmol"},{"key":"1630_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/bjo.57.8.608","volume":"57","author":"D Mooney","year":"1973","unstructured":"Mooney\u00a0D (1973) Angle recession and secondary glaucoma. Br J Ophthalmol 57:608\u2013612. https:\/\/doi.org\/10.1136\/bjo.57.8.608","journal-title":"Br J Ophthalmol"},{"key":"1630_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archopht.1964.00970020041010","volume":"72","author":"FM Blanton","year":"1964","unstructured":"Blanton\u00a0FM (1964) Anterior chamber angle recession and secondary glaucoma: a\u00a0study of the aftereffects of traumatic hyphemas. Arch Ophthalmol 72:39\u201343. https:\/\/doi.org\/10.1001\/archopht.1964.00970020041010","journal-title":"Arch Ophthalmol"},{"key":"1630_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10792-014-0027-5","volume":"35","author":"DS-C Ng","year":"2015","unstructured":"Ng\u00a0DS\u2011C, Ching\u00a0RH\u2011Y, Chan\u00a0CW\u2011N (2015) Angle-recession glaucoma: long-term clinical outcomes over a\u00a010-year period in traumatic microhyphema. Int Ophthalmol 35:107\u2013113. https:\/\/doi.org\/10.1007\/s10792-014-0027-5","journal-title":"Int Ophthalmol"},{"key":"1630_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-2008-1057629","volume":"177","author":"H Thiel","year":"1980","unstructured":"Thiel\u00a0H, Aden\u00a0G, P\u00fclhorn\u00a0G (1980) Kammerwinkelver\u00e4nderungen und Augeninnendruck nach Bulbuskontusionen. Klin Monbl Augenheilkd 177:165\u2013173. https:\/\/doi.org\/10.1055\/s-2008-1057629","journal-title":"Klin Monbl Augenheilkd"},{"key":"1630_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bjo.85.2.159","volume":"85","author":"T Manners","year":"2001","unstructured":"Manners\u00a0T, Salmon\u00a0JF, Barron\u00a0A et al (2001) Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. Br J Ophthalmol 85:159\u2013163. https:\/\/doi.org\/10.1136\/bjo.85.2.159","journal-title":"Br J Ophthalmol"},{"key":"1630_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5005\/jp-journals-10008-1215","volume":"11","author":"A Yadgarov","year":"2017","unstructured":"Yadgarov\u00a0A, Liu\u00a0D, Crane\u00a0ES, Khouri\u00a0AS (2017) Surgical outcomes of Ahmed or Baerveldt tube shunt implantation for medically uncontrolled traumatic glaucoma. J\u00a0Curr Glaucoma Pract 11:16\u201321. https:\/\/doi.org\/10.5005\/jp-journals-10008-1215","journal-title":"J Curr Glaucoma Pract"},{"key":"1630_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.18240\/ijo.2020.06.12","volume":"13","author":"AM Elhusseiny","year":"2020","unstructured":"Elhusseiny\u00a0AM, Lee\u00a0RK, Smiddy\u00a0WE (2020) Surgical management of uveitis-glaucoma-hyphema syndrome. Int J Ophthalmol 13:935\u2013940. https:\/\/doi.org\/10.18240\/ijo.2020.06.12","journal-title":"Int J Ophthalmol"},{"key":"1630_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/iae.0b013e318217fffb","volume":"32","author":"L Koreen","year":"2012","unstructured":"Koreen\u00a0L, Yoshida\u00a0N, Escariao\u00a0P et al (2012) Incidence of, risk factors for, and combined mechanism of late-onset open-angle glaucoma after vitrectomy. Retina 32:160\u2013167. https:\/\/doi.org\/10.1097\/iae.0b013e318217fffb","journal-title":"Retina"},{"key":"1630_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajo.2006.02.014","volume":"141","author":"S Chang","year":"2006","unstructured":"Chang\u00a0S (2006) LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol 141:1033\u20131043.e1. https:\/\/doi.org\/10.1016\/j.ajo.2006.02.014","journal-title":"Am J Ophthalmol"},{"key":"1630_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s003470050539","volume":"97","author":"A Gandorfer","year":"2000","unstructured":"Gandorfer\u00a0A, Kampik\u00a0A (2000) Expansion intraokularer Gase infolge Reduktion des Atmosph\u00e4rendruckes Kasuistik und Literatur\u00fcbersicht. Ophthalmologe 97:367\u2013370. https:\/\/doi.org\/10.1007\/s003470050539","journal-title":"Ophthalmologe"},{"key":"1630_CR51","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00417-009-1155-x","volume":"247","author":"P Ichhpujani","year":"2009","unstructured":"Ichhpujani\u00a0P, Jindal\u00a0A, Katz\u00a0LJ (2009) Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol 247:1585\u20131593. https:\/\/doi.org\/10.1007\/s00417-009-1155-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1630_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00061198-200104000-00006","volume":"10","author":"JB Jonas","year":"2001","unstructured":"Jonas\u00a0JB, Knorr\u00a0HLJ, Rank\u00a0RM, Budde\u00a0WM (2001) Intraocular pressure and silicone oil endotamponade. J\u00a0Glaucoma 10:102\u2013108. https:\/\/doi.org\/10.1097\/00061198-200104000-00006","journal-title":"J Glaucoma"},{"key":"1630_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10384-012-0171-2","volume":"56","author":"T Inoue","year":"2012","unstructured":"Inoue\u00a0T, Inatani\u00a0M, Takihara\u00a0Y et\u00a0al (2012) Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy. Jpn J Ophthalmol 56:464\u2013469. https:\/\/doi.org\/10.1007\/s10384-012-0171-2","journal-title":"Jpn J Ophthalmol"},{"key":"1630_CR54","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/s0161-6420(87)33537-7","volume":"94","author":"CL Shields","year":"1987","unstructured":"Shields\u00a0CL, Shields\u00a0JA, Shields\u00a0MB, Augsburger\u00a0JJ (1987) Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology 94:839\u2013846. https:\/\/doi.org\/10.1016\/s0161-6420(87)33537-7","journal-title":"Ophthalmology"},{"key":"1630_CR55","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s10792-020-01348-x","volume":"40","author":"VS Vempuluru","year":"2020","unstructured":"Vempuluru\u00a0VS, Jakati\u00a0S, Krishnamurthy\u00a0R et\u00a0al (2020) Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. Int Ophthalmol 40:1789\u20131795. https:\/\/doi.org\/10.1007\/s10792-020-01348-x","journal-title":"Int Ophthalmol"},{"key":"1630_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1746-1596-1-45","volume":"1","author":"PR Pereira","year":"2006","unstructured":"Pereira\u00a0PR, Odashiro\u00a0AN, Filho\u00a0JPS et\u00a0al (2006) Malignancy in the blind painful eye\u2014report of two cases and literature review. Diagn Pathol 1:45\u201345. https:\/\/doi.org\/10.1186\/1746-1596-1-45","journal-title":"Diagn Pathol"},{"key":"1630_CR57","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/archopht.1990.01070110103033","volume":"108","author":"HE Grossniklaus","year":"1990","unstructured":"Grossniklaus\u00a0HE, Brown\u00a0RH, Stulting\u00a0RD, Blasberg\u00a0RD (1990) Iris melanoma seeding through a\u00a0trabeculectomy site. Arch Ophthalmol 108:1287\u20131290. https:\/\/doi.org\/10.1001\/archopht.1990.01070110103033","journal-title":"Arch Ophthalmol"},{"key":"1630_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00061198-200202000-00013","volume":"11","author":"CA Girkin","year":"2002","unstructured":"Girkin\u00a0CA, Goldberg\u00a0I, Mansberger\u00a0SL et\u00a0al (2002) Management of iris melanoma with secondary glaucoma. J\u00a0Glaucoma 11:71\u201374. https:\/\/doi.org\/10.1097\/00061198-200202000-00013","journal-title":"J Glaucoma"},{"key":"1630_CR59","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00347-018-0828-4","volume":"116","author":"R Greslechner","year":"2019","unstructured":"Greslechner\u00a0R, Oberacher-Velten\u00a0I (2019) Glaukome durch erh\u00f6hten episkleralen Venendruck. Ophthalmologe 116:423\u2013429","journal-title":"Ophthalmologe"},{"key":"1630_CR60","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0021-5155(02)00542-7","volume":"46","author":"H Sakai","year":"2002","unstructured":"Sakai\u00a0H, Sakima\u00a0N, Nakamura\u00a0Y et al (2002) Ciliochoroidal effusion induced by topical latanoprost in a\u00a0patient with Sturge-Weber syndrome. Jpn J Ophthalmol 46:553\u2013555. https:\/\/doi.org\/10.1016\/s0021-5155(02)00542-7","journal-title":"Jpn J Ophthalmol"},{"key":"1630_CR61","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/s0181-5512(08)74730-2","volume":"31","author":"J Gambrelle","year":"2008","unstructured":"Gambrelle\u00a0J, Denis\u00a0P, Kocaba\u00a0V, Grange\u00a0JD (2008) Uveal effusion induced by topical travoprost in a\u00a0patient with Sturge-Weber-Krabbe syndrome. J\u00a0Fr Ophtalmol 31:e19. https:\/\/doi.org\/10.1016\/s0181-5512(08)74730-2","journal-title":"J Fr Ophtalmol"},{"key":"1630_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1600-0420.2006.00723.x","volume":"84","author":"F Audren","year":"2006","unstructured":"Audren\u00a0F, Abitbol\u00a0O, Dureau\u00a0P et al (2006) Non-penetrating deep sclerectomy for glaucoma associated with Sturge-Weber syndrome. Acta Ophthalmol Scand 84:656\u2013660. https:\/\/doi.org\/10.1111\/j.1600-0420.2006.00723.x","journal-title":"Acta Ophthalmol Scand"},{"key":"1630_CR63","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00347-015-0213-5","volume":"113","author":"S Kazerounian","year":"2016","unstructured":"Kazerounian\u00a0S, Rickmann\u00a0A, Helaiwa\u00a0K, Waizel\u00a0M (2016) Management des Radius-Maumenee-Syndroms. Ophthalmologe 113:775\u2013778. https:\/\/doi.org\/10.1007\/s00347-015-0213-5","journal-title":"Ophthalmologe"},{"key":"1630_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-2008-1054402","volume":"184","author":"K Ruprecht","year":"1984","unstructured":"Ruprecht\u00a0K, Naumann\u00a0G (1984) Einseitiges sekund\u00e4res Offenwinkelglaukom bei idiopathisch dilatierten episkleralen Gef\u00e4\u00dfen. Klin Monbl Augenheilkd 184:23\u201327. https:\/\/doi.org\/10.1055\/s-2008-1054402","journal-title":"Klin Monbl Augenheilkd"},{"key":"1630_CR65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00347-007-1519-8","volume":"104","author":"R L\u00e4mmer","year":"2007","unstructured":"L\u00e4mmer\u00a0R (2007) Sekund\u00e4res Offenwinkelglaukom mit idiopathischer episkleraler Venenstauung (Radius-Maumenee-Syndrom). Ophthalmologe 104:515\u2013516. https:\/\/doi.org\/10.1007\/s00347-007-1519-8","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01630-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T10:17:57Z","timestamp":1651832277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01630-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1630"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01630-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"24 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>R.\u00a0Greslechner<\/b>: A.\u00a0Finanzielle Interessen: gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt, Universit\u00e4tsklinikum Regensburg (Oberarzt Augenklinik) | Mitgliedschaften: Deutsche Ophthalmologische Gesellschaft, \u00d6sterreichische Ophthalmologische Gesellschaft.<b> H.\u00a0Helbig<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung von BMBF Jackst\u00e4dt-Stiftung, Velux Stiftung, Novartis Pharma, DFG f\u00fcr Forschungsvorhaben des Lehrstuhls, nicht zur freien pers\u00f6nlichen Verf\u00fcgung.\u00a0\u2013 Vortragshonorare und Reisekostenerstattung: Novartis, Bayer, Allergan, Alimera, Alcon, Apellis, Roche.\u00a0\u2013 Advisory board f\u00fcr: Allergan, Bayer, Implantdata, Th\u00e9a Pharma, Apellis, Roche und Novartis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter am UKR | Vorstand RG, Pressesprecher DOG | Mitgliedschaften: DOG, RG, BVA, ARVO, AAO, Euretina, DHV | H.\u00a0Helbig ist Mitglied des Herausgeberboards von <i>Der Ophthalmologe<\/i>. Er war nicht an der Begutachtung dieses Manuskripts durch die Zeitschrift oder an Entscheidungen in Bezug auf dieses Manuskript beteiligt.<b> D.\u00a0Spiegel<\/b>: A.\u00a0Finanzielle Interessen: gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Niedergelassener Augenarzt (Augenzentrum M\u00fcnchen S\u00fcd); Konsiliararzt (Universit\u00e4tsklinikum Regensburg).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}